Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

Pages: 143 Published: November 30, 2021 Report Code: GMDGDHC13184IDB

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes, and dry cough. Treatment includes antibiotics.

The Pertussis drugs in development market research report provides comprehensive information on the therapeutics under development for pertussis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for pertussis and features dormant and discontinued projects.

What are the key targets in the pertussis pipeline products market?

The key targets in the pertussis pipeline products market are Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, Bordetella pertussis Pertactin, Bordetella pertussis Pertussis Toxin S1 Subunit, Cells Expressing Stabilin 1, Hemagglutinin, and Toll Like Receptor 9.

Pertussis Pipeline Products Market Analysis by Targets

Pertussis Pipeline Products Market Analysis by Targets

For more target insights, download a free report sample

What are the key mechanisms of action in the pertussis pipeline products market?

The key mechanisms of action in the pertussis pipeline products market are Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor, Cytotoxic To Cells Expressing Stabilin 1, and Pertussis Toxin Inhibitor.

Pertussis Pipeline Products Market Analysis by Mechanism of Actions

Pertussis Pipeline Products Market Analysis by Mechanism of Actions

For more mechanism of actions insights, download a free report sample

What are the key routes of administration in the pertussis pipeline products market?

The key routes of administration in the pertussis pipeline products market are intramuscular, nasal, subcutaneous, oral, cutaneous, intravenous, and parenteral.

Pertussis Pipeline Products Market Analysis by Routes of Administration

Pertussis Pipeline Products Market Analysis by Routes of Administration

For more routes of administration insights, download a free report sample

What are the different molecule types in the pertussis pipeline products market?

The different molecule types in the pertussis pipeline products market are toxoid vaccine, vaccine, inactivated vaccine, conjugate vaccine, subunit vaccine, live attenuated vaccine, monoclonal antibody, small molecule, DNA vaccine, and recombinant vector vaccine.

Pertussis Pipeline Products Market Analysis by Molecule Type

Pertussis Pipeline Products Market Analysis by Molecule TypeTo know more about molecule types, download a free report sample

Which are the major companies in the pertussis pipeline products market?

Some of the major companies in the pertussis pipeline products market are Serum Institute of India Pvt Ltd, Beijing Minhai Biotechnology Co Ltd, CanSino Biologics Inc, AIM Vaccine Co Ltd, Biological E Ltd, GlaxoSmithKline Plc, ILiAD Biotechnologies LLC, KM Biologics Co Ltd, Olymvax Biopharmaceuticals Inc, and Suzhou Weichao Biotechnology Co Ltd.

Pertussis Pipeline Products Market Analysis by Companies

Pertussis Pipeline Products Market Analysis by Companies

To know more about major companies, download a free report sample

Market Report Scope

Key targets Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, Bordetella pertussis Pertactin, Bordetella pertussis Pertussis Toxin S1 Subunit, Cells Expressing Stabilin 1, Hemagglutinin, and Toll Like Receptor 9
Key mechanism of action Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor, Cytotoxic To Cells Expressing Stabilin 1, and Pertussis Toxin Inhibitor
Key routes of administration Intramuscular, Nasal, Subcutaneous, Oral, Cutaneous, Intravenous, and Parenteral
Molecule type Toxoid Vaccine, Vaccine, Inactivated Vaccine, Conjugate Vaccine, Subunit Vaccine, Live Attenuated Vaccine, Monoclonal Antibody, Small Molecule, DNA Vaccine, and Recombinant Vector Vaccine
Major companies Serum Institute of India Pvt Ltd, Beijing Minhai Biotechnology Co Ltd, CanSino Biologics Inc, AIM Vaccine Co Ltd, Biological E Ltd, GlaxoSmithKline Plc, ILiAD Biotechnologies LLC, KM Biologics Co Ltd, Olymvax Biopharmaceuticals Inc, and Suzhou Weichao Biotechnology Co Ltd

Scope

  • The report provides a snapshot of the global therapeutic landscape of Pertussis (Whooping Cough)
  • The report reviews pipeline therapeutics for Pertussis (Whooping Cough) by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Pertussis (Whooping Cough) therapeutics and enlists all their major and minor projects
  • The report assesses Pertussis (Whooping Cough) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews the latest news related to pipeline therapeutics for Pertussis (Whooping Cough)

Reasons to Buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Pertussis (Whooping Cough)
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Pertussis (Whooping Cough) pipeline depth and focus on Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from the pipeline

Key Players

  • Adjuvance Technologies Inc

    AIM Vaccine Co Ltd

    Beijing Minhai Biotechnology Co Ltd

    Beijing Tiantan Biological Products Co Ltd

    Bharat Biotech Ltd

    Biken Co Ltd

    Biological E Ltd

    BioNet-Asia Co Ltd

    Boryung Pharmaceutical Co Ltd

    Cadila Healthcare Ltd

    CanSino Biologics Inc

    Changchun Bcht Biotechnology Co Ltd

    Chongqing Zhifei Biological Products Co Ltd

    DBV Technologies SA

    Dynavax Technologies Corp

    Faron Pharmaceuticals Oy

    Gamaleya Federal Research Center of Epidemiology and Microbiology

    GC Pharma

    GlaxoSmithKline Plc

    ILiAD Biotechnologies LLC

    KM Biologics Co Ltd

    LG Chem Ltd

    Novo Medi Sciences Pvt Ltd

    Olymvax Biopharmaceuticals Inc

    Panacea Biotec Ltd

    Sanofi

    Serum Institute of India Pvt Ltd

    Shantha Biotechnics Pvt Ltd

    Suzhou Weichao Biotechnology Co Ltd

    Synthetic Biologics Inc

    VaxForm LLC

    Yisheng Biopharma Co Ltd

Table of Contents

Table of Contents

Introduction

Global Markets Direct Report Coverage

Pertussis – Overview

Pertussis – Therapeutics Development

Pertussis – Therapeutics Assessment

Pertussis – Companies Involved in Therapeutics Development

Pertussis – Drug Profiles

Pertussis – Dormant Projects

Pertussis – Discontinued Products

Pertussis – Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Pertussis (Whooping Cough), 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Companies, 2021 (Contd..1)

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Companies, 2021 (Contd..1)

Products under Development by Companies, 2021 (Contd..2)

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Pertussis (Whooping Cough) – Pipeline by Adjuvance Technologies Inc, 2021

Pertussis (Whooping Cough) – Pipeline by AIM Vaccine Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Beijing Minhai Biotechnology Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Beijing Tiantan Biological Products Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Bharat Biotech Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Biken Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Biological E Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by BioNet-Asia Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Boryung Pharmaceutical Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Cadila Healthcare Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by CanSino Biologics Inc, 2021

Pertussis (Whooping Cough) – Pipeline by Changchun Bcht Biotechnology Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by DBV Technologies SA, 2021

Pertussis (Whooping Cough) – Pipeline by Dynavax Technologies Corp, 2021

Pertussis (Whooping Cough) – Pipeline by Faron Pharmaceuticals Oy, 2021

Pertussis (Whooping Cough) – Pipeline by Gamaleya Federal Research Center of Epidemiology and Microbiology, 2021

Pertussis (Whooping Cough) – Pipeline by GC Pharma, 2021

Pertussis (Whooping Cough) – Pipeline by GlaxoSmithKline Plc, 2021

Pertussis (Whooping Cough) – Pipeline by ILiAD Biotechnologies LLC, 2021

Pertussis (Whooping Cough) – Pipeline by KM Biologics Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by LG Chem Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Novo Medi Sciences Pvt Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Olymvax Biopharmaceuticals Inc, 2021

Pertussis (Whooping Cough) – Pipeline by Panacea Biotec Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Sanofi, 2021

Pertussis (Whooping Cough) – Pipeline by Serum Institute of India Pvt Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Shantha Biotechnics Pvt Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Suzhou Weichao Biotechnology Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Synthetic Biologics Inc, 2021

Pertussis (Whooping Cough) – Pipeline by VaxForm LLC, 2021

Pertussis (Whooping Cough) – Pipeline by Yisheng Biopharma Co Ltd, 2021

Pertussis (Whooping Cough) – Dormant Projects, 2021

Pertussis (Whooping Cough) – Dormant Projects, 2021 (Contd..1)

Pertussis (Whooping Cough) – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Pertussis (Whooping Cough), 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Targets, 2021

Number of Products by Stage and Targets, 2021

Number of Products by Mechanism of Actions, 2021

Number of Products by Stage and Mechanism of Actions, 2021

Number of Products by Routes of Administration, 2021

Number of Products by Stage and Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

Frequently Asked Questions

$2000

Can be used by individual purchaser only

$6000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.